IMNN
Income statement / Annual
Last year (2023), Imunon, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Imunon, Inc.'s net income was -$19.51 M.
See Imunon, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00
|
$500,000.00
|
$500,000.00
|
$500,000.00
|
$500,000.00
|
$500,000.00
|
$500,000.00
|
$500,000.00
|
$500,000.00
|
$500,000.00
|
| Cost of Revenue |
$720,005.00 |
$731,629.00 |
$702,918.00 |
$11.34 M |
$13.07 M |
$11.07 M |
$13.08 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$720,005.00 |
-$231,629.00 |
-$202,918.00 |
-$10.84 M |
-$12.57 M |
-$10.57 M |
-$12.58 M |
$500,000.00 |
$500,000.00 |
$500,000.00 |
| Gross Profit Ratio |
0 |
-0.46 |
-0.41 |
-21.69 |
-25.13 |
-21.13 |
-25.16 |
1 |
1 |
1 |
| Research and Development
Expenses |
$11.29 M
|
$11.73 M
|
$10.62 M
|
$11.34 M
|
$13.07 M
|
$11.87 M
|
$13.08 M
|
$14.62 M
|
$14.66 M
|
$14.97 M
|
| General & Administrative
Expenses |
$9.74 M
|
$13.69 M
|
$10.89 M
|
$7.64 M
|
$8.00 M
|
$9.70 M
|
$5.89 M
|
$6.53 M
|
$6.69 M
|
$8.86 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.74 M
|
$13.69 M
|
$10.89 M
|
$7.64 M
|
$8.00 M
|
$9.70 M
|
$5.89 M
|
$6.53 M
|
$6.69 M
|
$8.86 M
|
| Other Expenses |
$0.00 |
$5.40 M |
$1.62 M |
-$1.30 M |
$3.19 M |
$3.63 M |
$651,971.00 |
$733,000.00 |
-$259,451.00 |
$265,886.00 |
| Operating Expenses |
$20.31 M |
$25.42 M |
$21.51 M |
$18.99 M |
$21.07 M |
$21.57 M |
$18.97 M |
$21.15 M |
$21.35 M |
$23.83 M |
| Cost And Expenses |
$21.03 M |
$25.42 M |
$21.51 M |
$18.99 M |
$21.07 M |
$21.57 M |
$18.97 M |
$21.15 M |
$21.35 M |
$23.83 M |
| Interest Income |
$0.00 |
$502,578.00 |
$18,145.00 |
$66,553.00 |
$442,987.00 |
$331,780.00 |
$26,041.00 |
$31,262.00 |
$186,322.00 |
$1.02 M |
| Interest Expense |
-$197.08 M |
$4.57 M |
$557,000.00 |
$1.29 M |
$1.39 M |
$712,025.00 |
$91,756.00 |
$693,000.00 |
$1.36 M |
$1.33 M |
| Depreciation &
Amortization |
$720,005.00
|
$731,629.00
|
$702,918.00
|
$741,524.00
|
$721,665.00
|
$356,859.00
|
$553,010.00
|
$1.03 M
|
$424,966.00
|
$369,327.00
|
| EBITDA |
-$19.88 M
|
-$31.71 M
|
-$20.88 M
|
-$21.30 M
|
-$16.55 M
|
-$21.23 M
|
-$19.76 M
|
-$20.30 M
|
-$20.67 M
|
-$23.79 M
|
| EBITDA Ratio |
0 |
-39.05 |
-38.77 |
-37.96 |
-32.42 |
-33.49 |
-34.47 |
-39.83 |
-40.99 |
-43.36 |
| Operating Income Ratio
|
0
|
-49.84
|
-42.01
|
-36.97
|
-41.13
|
-42.13
|
-36.94
|
-41.3
|
-41.69
|
-49.43
|
| Total Other
Income/Expenses Net |
$235,068.00
|
-$12.54 M
|
-$1.15 M
|
-$4.84 M
|
$1.90 M
|
-$1.24 M
|
-$1.93 M
|
-$1.40 M
|
-$1.61 M
|
-$779,079.00
|
| Income Before Tax |
-$20.80 M |
-$37.47 M |
-$22.15 M |
-$23.33 M |
-$18.67 M |
-$22.30 M |
-$20.40 M |
-$22.05 M |
-$22.46 M |
-$25.49 M |
| Income Before Tax Ratio
|
0
|
-74.93
|
-44.31
|
-46.66
|
-37.34
|
-44.6
|
-40.8
|
-44.11
|
-44.92
|
-50.99
|
| Income Tax Expense |
-$1.28 M |
-$1.57 M |
-$1.38 M |
-$1.85 M |
-$1.82 M |
-$10.42 M |
$1.93 M |
$1.40 M |
$1.61 M |
$779,079.00 |
| Net Income |
-$19.51 M |
-$35.90 M |
-$20.77 M |
-$21.48 M |
-$16.85 M |
-$11.88 M |
-$20.40 M |
-$22.05 M |
-$22.46 M |
-$25.49 M |
| Net Income Ratio |
0 |
-71.8 |
-41.54 |
-42.97 |
-33.7 |
-23.77 |
-40.8 |
-44.11 |
-44.92 |
-50.99 |
| EPS |
-2.16 |
-5.03 |
-3.6 |
-10.08 |
-11.58 |
-10.14 |
-40.12 |
-178.43 |
-216.24 |
-289.83 |
| EPS Diluted |
-2.16 |
-5.03 |
-3.6 |
-10.08 |
-11.58 |
-10.14 |
-40.12 |
-178.42 |
-216.24 |
-289.83 |
| Weighted Average Shares
Out |
$9.05 M
|
$7.14 M
|
$5.77 M
|
$2.13 M
|
$1.46 M
|
$1.17 M
|
$508,480.00
|
$123,603.00
|
$103,872.00
|
$87,964.00
|
| Weighted Average Shares
Out Diluted |
$9.05 M
|
$7.14 M
|
$5.77 M
|
$2.13 M
|
$1.46 M
|
$1.17 M
|
$508,483.00
|
$123,604.00
|
$103,873.00
|
$87,964.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
